On the other hand, CD44 was validated as a key regulator of WNT (37), PI3K/AKT (8) and MAPK/ERK signaling pathways (29), thereby supporting our hypothesis that PCF11 is a potential novel transcriptional target that underpins CD44/HA-promoted tumor cell invasion. Here, CD44 is linked to neoplasm.